Incidence and Mortality of Acute Kidney Injury after Myocardial Infarction: A Comparison between KDIGO and RIFLE Criteria

Carregando...
Imagem de Miniatura
Citações na Scopus
74
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
RODRIGUES, Fernando B.
BRUETTO, Rosana G.
TORRES, Ulysses S.
OTAVIANO, Ana P.
ZANETTA, Dirce M. T.
Citação
PLOS ONE, v.8, n.7, article ID e69998, 8p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Acute kidney injury (AKI) increases the risk of death after acute myocardial infarction (AMI). Recently, a new AKI definition was proposed by the Kidney Disease Improving Global Outcomes (KDIGO) organization. The aim of the current study was to compare the incidence and the early and late mortality of AKI diagnosed by RIFLE and KDIGO criteria in the first 7 days of hospitalization due to an AMI. Methods and Results: In total, 1,050 AMI patients were prospectively studied. AKI defined by RIFLE and KDIGO occurred in 14.8% and 36.6% of patients, respectively. By applying multivariate Cox analysis, AKI was associated with an increased adjusted hazard ratio (AHR) for 30-day death of 3.51 (95% confidence interval [CI] 2.35-5.25, p<0.001) by RIFLE and 3.99 (CI 2.59-6.15, p<0.001) by KDIGO and with an AHR for 1-year mortality of 1.84 (CI 1.12-3.01, p = 0.016) by RIFLE and 2.43 (CI 1.62-3.62, p<0.001) by KDIGO. The subgroup of patients diagnosed as non-AKI by RIFLE but as AKI by KDIGO criteria had also an increased AHR for death of 2.55 (1.52-4.28) at 30 days and 2.28 (CI 1.46-3.54) at 1 year (p<0.001). Conclusions: KDIGO criteria detected substantially more AKI patients than RIFLE among AMI patients. Patients diagnosed as AKI by KDIGO but not RIFLE criteria had a significantly higher early and late mortality. In this study KDIGO criteria were more suitable for AKI diagnosis in AMI patients than RIFLE criteria.
Palavras-chave
Referências
  1. Amin AP, 2010, AM HEART J, V160, P1065, DOI 10.1016/j.ahj.2010.08.007
  2. Amin AP, 2012, ARCH INTERN MED, V172, P246, DOI 10.1001/archinternmed.2011.1202
  3. Anzai A, 2010, J CARD FAIL, V16, P381, DOI 10.1016/j.cardfail.2009.12.020
  4. Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872
  5. Bruetto RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035496
  6. Cheitlin MD, 1997, J AM COLL CARDIOL, V29, P862
  7. Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25
  8. Englberger L, 2011, CRIT CARE, V15, DOI 10.1186/cc9960
  9. Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055
  10. Hwang SH, 2011, INT J CARDIOL, V150, P99, DOI 10.1016/j.ijcard.2011.03.039
  11. Jose P, 2006, J AM SOC NEPHROL, V17, P2886, DOI 10.1681/ASN.2006010063
  12. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S1, P1
  13. Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD
  14. Lazaros G, 2012, INT J CARDIOL, V155, P97, DOI 10.1016/j.ijcard.2010.10.024
  15. Levey AS, 1999, ANN INTERN MED, V130, P461
  16. Marenzi G, 2010, CRIT CARE MED, V38, P438, DOI 10.1097/CCM.0b013e3181b9eb3b
  17. Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713
  18. Mielniczuk LM, 2009, CLIN J AM SOC NEPHRO, V4, P1811, DOI 10.2215/CJN.03510509
  19. Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609
  20. Ostermann M, 2011, QJM-INT J MED, V104, P237, DOI 10.1093/qjmed/hcq185
  21. Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987
  22. Pickering JW, 2013, CRIT CARE, V17, DOI 10.1186/cc11931
  23. Pickering JW, 2009, LANCET, V373, P1318, DOI 10.1016/S0140-6736(09)60751-0
  24. Praught ML, 2005, CURR OPIN NEPHROL HY, V14, P265, DOI 10.1097/01.mnh.0000165894.90748.72
  25. Rodrigues FB, 2010, CLIN J AM SOC NEPHRO, V5, P1530, DOI 10.2215/CJN.01260210
  26. Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397